tiprankstipranks
Bioxcel Therapeutics (BTAI)
:BTAI
US Market
Holding BTAI?
Track your performance easily

Bioxcel Therapeutics (BTAI) Technical Analysis

1,363 Followers

Technical Sentiment

Overall Consensus
Sell
5Bullish
3Neutral
14Bearish
Technical Analysis Consensus
Buy
5Bullish
3Neutral
2Bearish
Moving Average Consensus
Strong Sell
0Bullish
0Neutral
12Bearish
Bioxcel Therapeutics’s (BTAI) Moving Averages Convergence Divergence (MACD) indicator is -0.02, suggesting Bioxcel Therapeutics is a Buy.
Bioxcel Therapeutics’s (BTAI) 20-Day exponential moving average is 0.39, while Bioxcel Therapeutics’s (BTAI) share price is $0.34, making it a Sell.
Bioxcel Therapeutics’s (BTAI) 50-Day exponential moving average is 0.45, while Bioxcel Therapeutics’s (BTAI) share price is $0.34, making it a Sell.

Bioxcel Therapeutics (BTAI) Pivot Points

Jan 21, 2025, 02:27 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
0.30
0.32
0.33
0.34
0.35
0.37
0.38
Fibonacci
0.32
0.33
0.33
0.34
0.35
0.36
0.37
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Bioxcel Therapeutics (BTAI) Moving Averages

Jan 21, 2025, 02:27 AM
Period
Simple
Exponential
MA5
0.35Sell
0.36Sell
MA10
0.40Sell
0.37Sell
MA20
0.38Sell
0.39Sell
MA50
0.46Sell
0.45Sell
MA100
0.53Sell
0.63Sell
MA200
1.09Sell
1.23Sell
Bioxcel Therapeutics’s (BTAI) 10-Day exponential moving average is 0.37, while Bioxcel Therapeutics’s (BTAI) share price is $0.34, making it a Sell.
Bioxcel Therapeutics’s (BTAI) 100-Day exponential moving average is 0.63, while Bioxcel Therapeutics’s (BTAI) share price is $0.34, making it a Sell.
Bioxcel Therapeutics’s (BTAI) stock price is $0.34 and Bioxcel Therapeutics’s (BTAI) 50-day simple moving average is 0.46, creating a Sell signal.
Bioxcel Therapeutics’s (BTAI) stock price is $0.34 and Bioxcel Therapeutics’s (BTAI) 100-day simple moving average is 0.53, creating a Sell signal.
Bioxcel Therapeutics’s (BTAI) stock price is $0.34 and Bioxcel Therapeutics’s (BTAI) 200-day simple moving average is 1.09, creating a Sell signal.

Bioxcel Therapeutics (BTAI) Technical Indicators

Jan 21, 2025, 02:27 AM
Name
Value
Implied Action
RSI (14)
41.35
Neutral
STOCH (9,6)
9.04
Buy
STOCHRSI (14)
9.04
Buy
MACD (12,26)
-0.02
Buy
ADX (14)
16.26
Buy
Williams %R
-92.25
Buy
CCI (14)
-74.29
Neutral
ATR (14)
0.06
-
Ultimate Oscillator
46.33
Neutral
ROC
-8.11
Sell
Bioxcel Therapeutics’s (BTAI) Relative Strength Index (RSI) is 41.35, creating a Neutral signal.
Bioxcel Therapeutics’s (BTAI) Trend Strength Indicator (ADX) is 16.26, creating a Buy signal.
Bioxcel Therapeutics’s (BTAI) Commodity Channel Index (CCI) is -74.29, creating a Neutral signal.
Bioxcel Therapeutics’s (BTAI) Price Rate of Change (ROC) is -8.11, creating a Sell signal.

FAQ

Is BTAI a Buy, Hold, or Sell?
Based on BTAI’s technical indicators, BTAI is a Sell.
    What is BTAI’s RSI (14)?
    BTAI’s RSI (14) is 41.35, which suggests BTAI is a Neutral.
      What is BTAI’s MACD?
      BTAI’s MACD is -0.02, which suggests BTAI is a Buy.
        What is BTAI’s 5-day moving average?
        BTAI’s 5-day moving average is 0.35, which suggests BTAI is a Sell.
          What is BTAI’s 20-day moving average?
          BTAI 20-day moving average is 0.38, which suggests BTAI is a Sell.
            What is BTAI’s 50-day moving average?
            BTAI’s 50-day moving average is 0.46, which suggests BTAI is a Sell.
              What is BTAI’s 200-day moving average?
              BTAI’s 200-day moving average is 1.09, which suggests BTAI is a Sell.
                What is BTAI’s Williams % R (14)?
                BTAI’s Williams % R (14) is -92.25, which suggests BTAI is a Buy.
                  What is BTAI’s CCI (14)?
                  BTAI’s CCI (14) is -74.29, which suggests BTAI is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis